CD41+/CD45+ Cells Without Acetylcholinesterase Activity Are Immature and a Major Megakaryocytic Population in Murine Bone Marrow
Authors:
Open Access
- 18 January 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 25 (4) , 862-870
Abstract
Murine megakaryocytes (MKs) are defined by CD41/CD61 expression and acetylcholinesterase (AChE) activity; however, their stages of differentiation in bone marrow (BM) have not been fully elucidated. In murine lineage-negative (Lin−)/CD45+ BM cells, we found CD41+ MKs without AChE activity (AChE−) except for CD41++ MKs with AChE activity (AChE+), in which CD61 expression was similar to their CD41 level. Lin−/CD41+/CD45+/AChE− MKs could differentiate into AChE+, with an accompanying increase in CD41/CD61 during in vitro culture. Both proplatelet formation (PPF) and platelet (PLT) production for Lin−/CD41+/CD45+/AChE− MKs were observed later than for Lin−/CD41++/CD45+/AChE+ MKs, whereas MK progenitors were scarcely detected in both subpopulations. GeneChip and semiquantitative polymerase chain reaction analyses revealed that the Lin−/CD41+/CD45+/AChE− MKs are assigned at the stage between the progenitor and PPF preparation phases in respect to the many MK/PLT-specific gene expressions, including β1-tubulin. In normal mice, the number of Lin−/CD41+/CD45+/AChE− MKs was 100 times higher than that of AChE+ MKs in BM. When MK destruction and consequent thrombocytopenia were caused by an antitumor agent, mitomycin-C, Lin−/CD41+/CD45+/AChE− MKs led to an increase in AChE+ MKs and subsequent PLT recovery with interleukin-11 administration. It was concluded that MKs in murine BM at least in part consist of immature Lin−/CD41+/CD45+/AChE− MKs and more differentiated Lin−/CD41++/CD45+/AChE+ MKs. Immature Lin−/CD41+/CD45+/AChE− MKs are a major MK population compared with AChE+ MKs in BM and play an important role in rapid PLT recovery in vivo. Disclosure of potential conflicts of interest is found at the end of this article.Keywords
This publication has 39 references indexed in Scilit:
- Thrombopoietic Factors in Chronic Bone Marrow Failure States: The Platelet Problem RevisitedClinical Cancer Research, 2005
- Recombinant human thrombopoietin: basic biology and evaluation of clinical studiesBlood, 2002
- Molecular and Transcriptional Regulation of Megakaryocyte DifferentiationStem Cells, 2001
- The P2Y12 receptor induces platelet aggregation through weak activation of the αIIbβ3 integrin – a phosphoinositide 3‐kinase‐dependent mechanismFEBS Letters, 2001
- A lineage-restricted and divergent β-tubulin isoform is essential for the biogenesis, structure and function of blood plateletsCurrent Biology, 2001
- Thrombopoietic Activity of Recombinant Human Interleukin-11 in Nonhuman Primates with ACNU-Induced ThrombocytopeniaJournal of Interferon & Cytokine Research, 2000
- The Efficacy of Recombinant Thrombopoietin in Murine and Nonhuman Primate Models for Radiation‐Induced Myelosuppression and Stem Cell TransplantationStem Cells, 1998
- Induction of c‐kit Molecules on Human CD34 + /c‐kit Cells: Evidence for CD34 + /c‐kit Cells as Primitive Hematopoietic Stem CellsStem Cells, 1997
- Long-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem CellScience, 1996
- Megakaryocyte colony‐stimulating factor (Meg‐CSF) is a unique cytokine specific for the megakaryocyte lineageBritish Journal of Haematology, 1993